Drutz David 4
4 · Altimmune, Inc. · Filed May 25, 2022
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2022-05-24$4.50/sh+1,200$5,400→ 19,012 total
Holdings
- 333(indirect: See Footnote)
Common Stock, par value $0.0001
Footnotes (1)
- [F1]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.